Key facts
- This page summarizes Chris M. Calcaterra's Form 4 filing for GLAUKOS Corp (GKOS).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 28 Mar 2022, 20:27.
Chris M. Calcaterra - 24 Mar 2022 Form 4 Insider Report for GLAUKOS Corp (GKOS)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- GKOS
- Reported as of
- 24 Mar 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 28 Mar 2022, 20:27:05 UTC
- Prior SEC filing
- 18 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Diana Scherer, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Chris M. Calcaterra filed Form 4 for GLAUKOS Corp (GKOS) on 28 Mar 2022.
Change
- Previous filing in this sequence was filed on 18 Mar 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GKOS
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +3,886
- Change %
- +2.2%
- Price
- $0.000000
- Shares after
- 181,594
- Date
- 24 Mar 2022
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GKOS
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +4,917
- Change %
- +77%
- Price
- $0.000000
- Shares after
- 11,301
- Date
- 24 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,917
- Exercise price
- $39.10
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 18, 2021, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. The Compensation Committee of the Issuer's Board of Directors (the "Compensation Committee") determined on March 24, 2022 the level of achievement for the first year of the multi-year performance period. The Reporting Person elected to receive this performance grant in the form of restricted stock units. The number of shares reported herein consists of the portion of the award that was deemed earned based upon the achievement with respect to the first-year performance goal. 50% of the number of shares of common stock reported herein will vest and be delivered on April 6, 2022 and the remaining 50% will vest and be delivered on January 6, 2023.
Footnote F2
Includes 21,787 restricted stock units that have not yet vested or been delivered to the Reporting Person.
Footnote F3
Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 12, 2020, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. The Compensation Committee of the Issuer's Board of Directors (the "Compensation Committee") determined on March 24, 2022 the level of achievement for the second year of the multi-year performance period. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement with respect to the second-year performance goal. The portion of the option reported herein will vest and become exercisable on April 1, 2022.